Sensata Technologies Holding Plc
—- Market cap
- —
- Debt
- —
- Cash
- −$573.00M
Complete market value, debt and cash evidence is required for enterprise value.
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
Decision snapshot: ST stock price vs A: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at A's multiple
Needs A P/E.
Implied fair value · at ST's multiple
Needs ST P/E.
Price unavailable
Metric by metric
Where each company leads, and how wide the gap is.
Growth lag
Reported gross margin
Operating income + D&A
Lower is better
Not comparable
Lower leverage
Statements
Annual statements in reported currencies, with calculations and source evidence.
Values retain reported currencies and share bases. Select a figure to inspect its period, calculation and filing inputs. Differences require compatible units and periods.
Explore enterprise value and market valuation multiples in the valuation sections.
Trendline
Eight period-end years of reported revenue, earnings, and margins. Periods and currencies are shown with the data.
Price framework
USD market cap plus reported borrowing debt, less cash and equivalents. This EV proxy excludes investments, preferred stock and noncontrolling-interest adjustments.
Complete market value, debt and cash evidence is required for enterprise value.
Complete market value, debt and cash evidence is required for enterprise value.
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
SENSATA TECHNOLOGIES HOLDING PLC · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
AGILENT TECHNOLOGIES, INC. · implied price per share
Bear
$41.49
Base
$49.80
Bull
$60.61
Balance sheet health
Inspect reported liquidity and leverage alongside historical financial-health checks.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Not enough data to score either balance sheet.
Cash excludes investments. EBITDA is an operating-income-plus-D&A proxy. Missing borrowing categories remain unavailable; select a value to inspect its inputs.
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
HONEYWELL INTERNATIONAL INC
ST vs HON
EMERSON ELECTRIC CO
ST vs EMR
TE Connectivity plc
ST vs TEL
AMPHENOL CORP /DE/
ST vs APH
AMETEK INC/
ST vs AME
Fortive Corp
ST vs FTV
THERMO FISHER SCIENTIFIC INC.
ST vs TMO
ILLUMINA, INC.
ST vs ILMN
BIO-TECHNE Corp
ST vs TECH
BRUKER CORP
ST vs BRKR
Azenta, Inc.
ST vs AZTA
WATERS CORP /DE/
ST vs WAT
LLM-powered synthesis
An explanation of the financial evidence. Check its snapshot date against the figures above.
This explanation uses an earlier data snapshot or evidence version. Review its generation date and the current figures, or refresh after signing in.
If you believe ST can reverse its -5.8% revenue decline and materially improve margins toward A levels, then hold or selectively own it; otherwise, the data favor reducing exposure because ST trades at 240.1x earnings while A shows much stronger profitability and balance-sheet resilience.
ST trades at a stark valuation premium on earnings quality-adjusted terms despite substantially weaker fundamentals than A, which makes the implied pricing gap look punitive rather than conservative. The current price of $50.42 sits near the top of ST's historical band and well above the DCF range, while the P/E-based implied price of $5.97 suggests severe downside if A-like multiples are applied.
Supporting Metrics